Original Research

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Bloomgren G, Sperling B, Cushing K, Wenten M

Therapeutics and Clinical Risk Management 2012, 8:313-321

Published Date: 20 June 2012